Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

974
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
974
Discharge Summary Forms01:31

Discharge Summary Forms

813
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
813
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Classification of Illness01:17

Classification of Illness

7.9K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.9K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

182
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
182
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supramolecular Assembly System for Transdermal Penetration of Self-Assembled Short Peptides.

ACS applied bio materials·2026
Same author

Chitosan-coated and sodium phytate-crosslinked porous starch microspheres for oral delivery of celastrol in colitis therapy.

International journal of biological macromolecules·2026
Same author

LKAN: A Kolmogorov-Arnold Network-Based Framework with Long-History Statistical Regularization for IMU Trajectory Estimation.

Sensors (Basel, Switzerland)·2026
Same author

Bibliometric analysis of exercise and cancer prognosis research: trends, thematic evolution, and global collaborations (2015-2024).

Frontiers in oncology·2026
Same author

Authors' reply: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026
Same author

Immune Evasion in Ovarian Cancer Peritoneal Metastasis: Mechanisms and Biomarker-Guided Therapeutic Matching.

Journal of cellular physiology·2026

Related Experiment Video

Updated: Sep 5, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Combining Machine Learning with a Rule-Based Algorithm to Detect and Identify Related Entities of Documented Adverse

Hui Xing Tan1, Chun Hwee Desmond Teo1, Pei San Ang1

  • 1Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore.

Drug Safety
|July 6, 2022
PubMed
Summary

A new hybrid model combines rule-based and machine learning to extract drug-adverse event pairs from discharge summaries. This approach improves identification of related terms, enhancing pharmacovigilance efforts.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Related Experiment Videos

Last Updated: Sep 5, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Area of Science:

  • Pharmacovigilance
  • Natural Language Processing
  • Health Informatics

Background:

  • Discharge summaries contain crucial adverse drug reaction (ADR) data.
  • Unstructured text in discharge summaries hinders ADR analysis for pharmacovigilance.
  • Existing machine learning methods struggle with accurate entity extraction for ADRs.

Purpose of the Study:

  • To develop a hybrid model for maximizing the capture of drug-adverse event pairs from discharge summaries.
  • To improve the identification and extraction of related drug and adverse event entities.
  • To enhance pharmacovigilance signal generation from clinical notes.

Main Methods:

  • A hybrid model integrating rule-based and machine learning algorithms was developed.
  • Rule-based component identifies adverse event entities near drug terms.
  • Machine learning component estimates relatedness between drug and adverse event entities.
  • Model validated on four independent, temporally and geographically diverse datasets.

Main Results:

  • The hybrid model achieved a recall of 0.80 (cross-validation), 0.80 (temporal), and 0.76 (geographical) on rule-restricted data.
  • Recall decreased to 0.68 (temporal) and 0.62 (geographical) when tested on unrestricted datasets.
  • Rule-based restriction reduced recall by 12-14% but improved identification of related drug-adverse event terms.

Conclusions:

  • The hybrid model shows good generalizability for external validation in pharmacovigilance.
  • Rule-based restrictions enhance the precision of identifying related drug-adverse event pairs.
  • This approach offers a promising method for extracting valuable ADR information from unstructured clinical text.